Literature DB >> 16224051

Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome.

Per Sjogren1, Samar Basu, Magdalena Rosell, Angela Silveira, Ulf de Faire, Bengt Vessby, Anders Hamsten, Mai-Lis Hellenius, Rachel M Fisher.   

Abstract

OBJECTIVE: The metabolic syndrome predisposes to the development of cardiovascular diseases. Oxidative stress and elevated circulating oxidized low-density lipoprotein (LDL) concentrations are related to cardiovascular disease and proposed to be features of the metabolic syndrome. F2-isoprostanes are lipid peroxidation products and considered the most reliable biomarkers of oxidative stress. METHODS AND
RESULTS: Plasma oxidized LDL (oxLDL) and urinary 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha; the major F2-isoprostane) were analyzed in a cross-sectional study of 289 healthy men (62 to 64 years of age). Individuals completed a 7-day dietary record, and fasting plasma insulin, lipid, and lipoprotein concentrations, LDL particle size, and inflammatory markers were determined. National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) criteria were used to define the metabolic syndrome and individuals were grouped according to the number of risk factors for the metabolic syndrome (0, [n=88; 30%]; > or =1, [n=179; 62%], metabolic syndrome [n=22; 8%]). Group comparisons revealed no differences for oxLDL, 8-iso-PGF2alpha, or reported intake of macronutrients, whereas C-reactive protein and interleukin-6 were increased in the metabolic syndrome. LDL cholesterol strongly determined oxLDL in univariate and multivariate analysis, but no relationship to 8-iso-PGF2alpha was found. In turn, 8-iso-PGF2alpha was related to reported intake of fat, fatty acids, and dietary antioxidants.
CONCLUSIONS: There were no increases in plasma oxLDL or measures of oxidative stress (urinary 8-iso-PGF2alpha) in these otherwise healthy 63-year-old men with the metabolic syndrome. Furthermore, no relationship between oxLDL and 8-iso-PGF2alpha was found, but our results suggest a role for dietary factors in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224051     DOI: 10.1161/01.ATV.0000190675.08857.3d

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  14 in total

1.  Oxidative stress in the metabolic syndrome.

Authors:  K Esposito; M Ciotola; B Schisano; L Misso; G Giannetti; A Ceriello; D Giugliano
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome.

Authors:  Raymond C-S Seet; Chung-Yung J Lee; Erle C H Lim; Amy M L Quek; Shan-Hong Huang; Chin-Meng Khoo; Barry Halliwell
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

3.  Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia.

Authors:  Anna Tavridou; Apostolos Efthimiadis; Ioannis Efthimiadis; Vangelis G Manolopoulos
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 4.  Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.

Authors:  Boris Hansel; Anatol Kontush; Dominique Bonnefont-Rousselot; Eric Bruckert; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

5.  LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets.

Authors:  R Colas; A Sassolas; M Guichardant; C Cugnet-Anceau; M Moret; P Moulin; M Lagarde; C Calzada
Journal:  Diabetologia       Date:  2011-08-17       Impact factor: 10.122

6.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.

Authors:  A Kotronen; V R Velagapudi; L Yetukuri; J Westerbacka; R Bergholm; K Ekroos; J Makkonen; M-R Taskinen; M Oresic; H Yki-Järvinen
Journal:  Diabetologia       Date:  2009-02-13       Impact factor: 10.122

7.  Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance.

Authors:  P Sjögren; J Sierra-Johnson; K Gertow; M Rosell; B Vessby; U de Faire; A Hamsten; M-L Hellenius; R M Fisher
Journal:  Diabetologia       Date:  2007-11-20       Impact factor: 10.122

8.  Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases.

Authors:  Beatrice Scazzocchio; Rosaria Varì; Massimo D'Archivio; Carmela Santangelo; Carmelina Filesi; Claudio Giovannini; Roberta Masella
Journal:  J Lipid Res       Date:  2009-01-09       Impact factor: 5.922

9.  Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts.

Authors:  Hanna Pohjantähti-Maaroos; Ari Palomäki; Päivi Kankkunen; Ruth Laitinen; Sari Husgafvel; Kalevi Oksanen
Journal:  Cardiovasc Diabetol       Date:  2010-08-20       Impact factor: 9.951

10.  Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study.

Authors:  Kiriaque B F Barbosa; Ana Carolina P Volp; Helen Hermana M Hermsdorff; Iñigo Navarro-Blasco; M Ángeles Zulet; J Alfredo Martínez; Josefina Bressan
Journal:  Lipids Health Dis       Date:  2011-04-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.